DUBLIN--(BUSINESS WIRE)--The "North America Electronic Clinical Outcome Assessment Market By Delivery Mode, By End Use, By Country, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.
The North America Electronic Clinical Outcome Assessment Solution Market (eCOA) is expected to witness market growth of 18.3% CAGR during the forecast period (2020-2026).
The US market dominated the North America Licensed enterprises eCOA Market by Country in 2019, thereby, achieving a market value of $69.8 Million by 2026.
The Canada market is experiencing a CAGR of 22.3% during (2020 - 2026).
Additionally, The Mexico market is expected to witness a CAGR of 21.4% during (2020 - 2026).
With an aim to collect patient data during clinical trials & observation studies, there is high utilization of eCOAs, including electronic ClinROs (Clinician Reported Outcomes), ObsROs (Observer Reported Outcomes), and ePROs (electronic Patient Reported Outcomes). The eCOA solutions are easily available and simple to use due to the technological advancements in the domain of eCOA.
The paper-based methods have witnessed a low demand in recent years, & this fact shows a range of advantages achieved through the usage of electronic technologies. Therefore, the market growth is anticipated to be fuelled due to these consistent technological advancements to offer an effective workflow. Some other parameters that fuel the market growth such as growing utilization of clinical trials studies by big pharma companies, biopharmaceutical companies, and increasing demand for cloud-based services.
Moreover, assessment systems are beneficial in detecting probable adverse conditions in advance for patients, which is essential in order to take preventive measures to minimize adverse effects in coming years. Using ePRO systems, real-time data of patients can be transferred from the patients to healthcare professionals with an aim for precise decision-making and the right assessment of a patient's health. Hence, these determinants is expected to encourage the adoption of these platforms over the upcoming years.
The growth of the eCOA market is expected to witness bright prospects due to many factors such as high R&D spending by pharmaceutical companies, increasing adoption of software solutions during research studies, a broad customer base, and supportive government investments to support clinical trials. Also, the market growth is driven by the growing deployment of eCOA by medical research professionals.
Scope of the Study
Market Segments covered in the Report:
By Delivery Mode
- Web-hosted eCOA
- Cloud-based eCOA
- Licensed enterprises eCOA
By End Use
- Contract Research Organizations (CROs)
- Academic Institutes
- Pharma & Biotech Companies
- Medical Device Manufacturers
- Rest of North America
- Oracle Corporation
- Dassault Systemes SE
- IQVIA Holdings, Inc.
- Parexel International Corporation (Pamplona Capital Management)
- IBM Corporation (Merge Healthcare)
- Signant Health
- ERT Clinical
- eClinical Solutions LLC
- Castor EDC
- Anju Software, Inc. (OmniComm Systems)
For more information about this report visit https://www.researchandmarkets.com/r/i8gr28